The LLP risk model: an individual risk prediction model for lung cancer.
about
Lung carcinogenesis by tobacco smokeLung cancer: epidemiology, etiology, and preventionBiomarkers of risk to develop lung cancer in the new screening eraImplementing lung cancer screening in the real world: opportunity, challenges and solutionsScreening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individualsLung cancer screening: past, present and futureComponents necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy StatementEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesGenetic risk prediction in complex diseaseComputed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trialLung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repositoryA test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in casesPrevious lung diseases and lung cancer risk: a systematic review and meta-analysisUpdates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemopreventionPrevious lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer ConsortiumThe role of DNA methylation as biomarkers in the clinical management of lung cancer.Demonstration program of population-based lung cancer screening in China: Rationale and study designRegulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinicEliciting symptoms interpreted as normal by patients with early-stage lung cancer: could GP elicitation of normalised symptoms reduce delay in diagnosis? Cross-sectional interview study.From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue fraScreening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Predicting lung cancer prior to surgical resection in patients with lung nodulesCancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer.Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapyLung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors.AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancerDevelopment and validation of a lung cancer risk prediction model for African-AmericansAn expanded risk prediction model for lung cancer.Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling.Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention.Comparison of discriminatory power and accuracy of three lung cancer risk models.Lung cancer screening: subsequent evidences of national lung screening trial.A review of cancer risk prediction models with genetic variants.Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model.Individualized risk prediction model for lung cancer in Korean menEvaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer.Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial eraA risk model for lung cancer incidenceFifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancer
P2860
Q24625044-761F6AA7-2D27-4BB9-B4E3-3CA6AC52E747Q24630167-3F00C95A-765A-4662-AE4B-D255B6700899Q26747784-3AB14468-83C8-41F2-ABE4-B838E1FE84AFQ26784107-3FE4E4A7-17D6-4FEB-81EB-D181D3F57BA2Q26799888-2BCD5DBE-5577-46B0-993B-21414DE03635Q26829339-CB904891-0F05-452D-A7DE-925B4E4570A9Q27021984-16383327-1C1C-46AC-AAFA-C467C53F3D2DQ27023830-9E394472-2801-4F7D-8A0C-3E6B2BB34F4CQ27027720-5E43676A-E35B-4D0A-8A57-627FDE44E484Q28285393-FAF5BB4E-013F-4665-A17C-7275353C4FF9Q28384727-2C0FC6AB-DF4F-4E17-970A-8F331EDA0DEAQ28384749-9EF12505-81C7-4B41-A963-1C7B926132E2Q28387390-2AF53839-76AB-468D-BFF9-5B877ABF009DQ28388931-690C8608-28AC-4348-B568-53BBDEE4D8D6Q28392363-FEE7E2BF-1658-450E-9EEC-B334403474C2Q30317739-779F9454-9593-4A90-ABE6-4CB6808AF4F4Q30386349-99B1B58D-E6C5-4178-83BD-FFAB7CE6C554Q30498812-CECF9061-2FE0-4531-8A6C-2578128D39CAQ30530822-790C8505-9CAD-4238-AB27-2BFDEDC27129Q30535897-96C36231-E751-450A-9370-C422260CC87AQ30543321-4B987D75-A5B5-4EAE-B1EA-AD8577764A6DQ30610197-A6B33327-230B-4061-A812-9FAAA5AD1367Q33560334-36D9441A-7E95-498F-BDC7-CB95C99719CCQ33599090-4ADC8AEA-9AAB-4E14-9C3D-4841D606FAE7Q33603681-2B5800C9-2489-4D71-B41C-C87F7FA8D90AQ33750741-9C83D4F8-E1F7-4A0F-AA7C-876B9AEDA569Q33788556-B3DD939E-26C4-4829-9BE1-3035D8C0FB6CQ33788568-3E26F98D-2E95-43CD-A636-5FD42463B789Q33825806-F5C1F527-15CB-4BA2-8641-589349D4AE69Q33936367-61958921-7EC9-49EB-B0EC-F71FCBE63E7BQ34059668-31E935DF-87B5-45DC-B8C6-07F86F9FA91FQ34195009-341E62E2-30F6-463E-AB04-C1FFE761A8ABQ34265269-FF79A388-376E-4DA2-A68E-9FCECB82C853Q34507724-2C24F1DF-14F0-4F6F-9A44-FDDBF0C2DF14Q34585888-A72C5963-0BF4-479D-B097-7944FB7CE3A3Q34611247-1F14B752-5DD0-4F06-B6A0-BCE54F8A2566Q34714126-88C4910F-CF23-4C43-AF0C-773A34625B74Q34840130-F53A0044-36F9-419F-9051-B441CEB15FA6Q34966064-01F8EBFE-67DE-41F0-9C19-5735F9CB6B56Q34976530-60503F3D-7E91-4B06-BBB6-7E2F768F8E4C
P2860
The LLP risk model: an individual risk prediction model for lung cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The LLP risk model: an individual risk prediction model for lung cancer.
@ast
The LLP risk model: an individual risk prediction model for lung cancer.
@en
type
label
The LLP risk model: an individual risk prediction model for lung cancer.
@ast
The LLP risk model: an individual risk prediction model for lung cancer.
@en
prefLabel
The LLP risk model: an individual risk prediction model for lung cancer.
@ast
The LLP risk model: an individual risk prediction model for lung cancer.
@en
P2093
P2860
P356
P1476
The LLP risk model: an individual risk prediction model for lung cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604158
P407
P577
2007-12-18T00:00:00Z